Svb Wealth LLC Moderna, Inc. Transaction History

Svb Wealth LLC

$4.01 Billion
Q2 2024

A detailed history of Svb Wealth LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Svb Wealth LLC holds 2,771 shares of MRNA stock, worth $182,193. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,771

Previous 3,382 18.07%

Holding current value

$182,193

Previous $360,000 8.61%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$101.21 - $166.61 $61,839 - $101,798	-611 Reduced 18.07%	2,771 $329,000
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $5,036 - $6,810	59 Added 1.78%	3,382 $360,000
Q4 2023 Jan 30, 2024	BUY	$69.51 - $104.43 $230,981 - $347,020	3,323 New	3,323 $330,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $206,067 - $299,273	-1,519 Reduced 40.49%	2,233 $342,000
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $115,420 - $204,789	975 Added 35.11%	3,752 $673,000
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $125,272 - $206,024	1,061 Added 61.83%	2,777 $329,000
Q2 2022 Aug 16, 2022	BUY	$117.13 - $176.59 $25,182 - $37,966	215 Added 14.32%	1,716 $245,000
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $20,739 - $38,548	164 Added 12.27%	1,501 $258,000
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $13,323 - $21,742	59 Added 4.62%	1,337 $340,000
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $41,939 - $91,564	189 Added 17.36%	1,278 $492,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $57,809 - $104,566	-445 Reduced 29.01%	1,089 $256,000
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $167,482 - $285,293	1,534 New	1,534 $201,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account